Samantha Mateos-Corella, MD

Articles by Samantha Mateos-Corella, MD

Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor

ByRegina Barragan-Carrillo, MD,Samantha Mateos-Corella, MD,Carlos Ortiz-Hidalgo, MD,Eva A Izquierdo-Echavarri, MD,Ricardo Castillejos-Molina, MD,Martín Angel,Ignacio Barragan-Arteaga,Thomas W. Flaig, MD,María T. Bourlon, MD, MSc, FASCO

December 17th 2021

In this edition of Clinical Quandaries, Regina Barragan-Carrillo, MD, and colleagues present a case of an 18-year-old man who has a 1-month history of nonpainful right testicular enlargement.

Latest Updated Articles

Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor
Published: December 17th 2021 | Updated:

Samantha Mateos-Corella, MD

Articles by Samantha Mateos-Corella, MD

Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC

FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer

Trastuzumab Deruxtecan Regimen Accepted for Review in HER2+ Breast Cancer

Monitoring Response to Radioligand Therapy in Prostate Cancer

KEYNOTE-B61 Trial Review